United Therapeutics Corp (UTHR)
274.41
+0.15
(+0.05%)
USD |
NASDAQ |
May 20, 11:53
United Therapeutics Gross Profit (Quarterly): 604.80M for March 31, 2024
Gross Profit (Quarterly) Chart
Historical Gross Profit (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 604.80M |
December 31, 2023 | 543.70M |
September 30, 2023 | 539.30M |
June 30, 2023 | 532.40M |
March 31, 2023 | 454.60M |
December 31, 2022 | 432.70M |
September 30, 2022 | 478.80M |
June 30, 2022 | 437.20M |
March 31, 2022 | 436.00M |
December 31, 2021 | 380.60M |
September 30, 2021 | 417.00M |
June 30, 2021 | 409.30M |
March 31, 2021 | 356.10M |
December 31, 2020 | 350.10M |
September 30, 2020 | 356.10M |
June 30, 2020 | 336.10M |
March 31, 2020 | 332.90M |
December 31, 2019 | 282.30M |
September 30, 2019 | 368.50M |
June 30, 2019 | 346.90M |
March 31, 2019 | 333.50M |
December 31, 2018 | 349.50M |
September 30, 2018 | 360.80M |
June 30, 2018 | 382.80M |
March 31, 2018 | 336.00M |
Date | Value |
---|---|
December 31, 2017 | 411.70M |
September 30, 2017 | 426.00M |
June 30, 2017 | 425.70M |
March 31, 2017 | 356.20M |
December 31, 2016 | 380.60M |
September 30, 2016 | 384.60M |
June 30, 2016 | 392.60M |
March 31, 2016 | 368.30M |
December 31, 2015 | 379.60M |
September 30, 2015 | 379.30M |
June 30, 2015 | 331.20M |
March 31, 2015 | 306.70M |
December 31, 2014 | 330.56M |
September 30, 2014 | 289.15M |
June 30, 2014 | 284.09M |
March 31, 2014 | 258.80M |
December 31, 2013 | 250.24M |
September 30, 2013 | 271.51M |
June 30, 2013 | 248.29M |
March 31, 2013 | 215.82M |
December 31, 2012 | 206.15M |
September 30, 2012 | 214.50M |
June 30, 2012 | 195.94M |
March 31, 2012 | 180.18M |
December 31, 2011 | 169.85M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Quarterly) Range, Past 5 Years
282.30M
Minimum
Dec 2019
604.80M
Maximum
Mar 2024
419.77M
Average
413.15M
Median
Gross Profit (Quarterly) Benchmarks
Liquidia Corp | 1.505M |
Ligand Pharmaceuticals Inc | 28.10M |
Esperion Therapeutics Inc | 127.66M |
Vertex Pharmaceuticals Inc | 2.348B |
ANI Pharmaceuticals Inc | 88.27M |